Table 7.

Independent predictors of 30-day death in the statin previous users subset of patients with clinically suspected VAP

	Adjusted hazard ratio	95% CI	P
Age	1.06	1.02-1.11	<0.01
SOFA day-1	1.16	1.03-1.32	0.02
Statin continuation after ICU admission	0.47	0.22-0.97	0.04

VAP, ventilator-associated pneumonia; CI, confidence interval; SOFA, sequential organ failure assessment; ICU, intensive care unit.